The impact of COVID-19 on breast cancer screening: a peek behind the lecture with Dr Katherine Crew

Written by Katherine Crew (Columbia University Irving Medical Center (NY, USA)

breast cancer screening

Please introduce yourself, your research background and current research interests. My name is Katherine Crew and I’m a breast medical oncologist at Columbia University Irving Medical Center in New York City (NY, USA). I also direct the Clinical Breast Cancer Prevention Program at the Herbert Irving Comprehensive Cancer Center. My research focuses on implementing breast cancer risk assessment into clinical practice and adopting risk-stratified approaches to breast cancer screening and prevention. How has the COVID-19 pandemic impacted breast cancer screening? Early during the COVID-19 pandemic in March 2020, there was a dramatic decrease in cancer screening, particularly mammography screening, by...

To view this content, please register now for access

It's completely free